Clinical trials
Ureteral Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Changhai Hospital | 3 |
| Eli Lilly and Company | 3 |
| Peking University First Hospital | 2 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| The Affiliated Hospital of Qingdao University | 1 |
| Tianjin Medical University Second Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ureteral Neoplasms | 11 |
| Urinary Bladder Neoplasms | 6 |
| Carcinoma, Transitional Cell | 3 |
| Neoplasm Metastasis | 3 |
| Prostatic Neoplasms | 3 |
| Urologic Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Esophageal Neoplasms | 2 |
| Hematuria | 2 |
| Ovarian Neoplasms | 2 |
Trials
Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.